The main objective of this study was to confirm skin acceptability of the product GINPI REF. GINPI BATCH: 10/06/2024 applied under normal use conditions in healthy female adult volunteers, under gynecological control, by means of the evaluation of organoleptic characteristics and subjective efficacy of the study product by the volunteers. Other (secondary) objective was the assessment of unexpected adverse events referred by the volunteers as well as possible reactions observed by the investigator.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Efficacy evaluation (volunteer)
Timeframe: 21 days (end of study)
Efficacy evaluation (volunteer)
Timeframe: 21 days (end of study)
Efficacy evaluation (volunteer)
Timeframe: 21 days (end of study)
Efficacy evaluation (volunteer)
Timeframe: 21 days (end of study)
Efficacy evaluation (volunteer)
Timeframe: 21 days (end of study)
Organoleptic properties evaluation (volunteer)
Timeframe: 21 days (end of study)
Organoleptic properties evaluation (volunteer)
Timeframe: 21 days (end of study)
Organoleptic properties evaluation (volunteer)
Timeframe: 21 days (end of study)